ICL Group Ltd. Investor Presentation December 2025

This filing contains an investor presentation by ICL Group Ltd. for December 2025. The presentation covers the company's strategies, market positions, and financial outlook. Key areas discussed include the specialty crop nutrition market, the functional food ingredients market, and non-food phosphate solutions. ICL highlights its strong presence in various geographies, a loyal customer base, and expertise in food ingredients. The company's strategy involves focusing on specific adjacent segments like texturants, acidulants, preservatives, and leavening agents, supported by strategic acquisitions and organic growth. A significant portion of the presentation addresses the Dead Sea Concession, detailing a Memorandum of Understanding (MOU) with the Israeli Government and the draft concession bill. This aims to provide financial and regulatory clarity, reduce business risks, and ensure business continuity. The long-term outlook projects significant EBITDA growth, with contributions from both concession-related and non-concession activities. The company also discusses portfolio optimization, focusing on core markets and assets, and evaluating non-synergistic businesses for potential divestment or partnership. Furthermore, ICL emphasizes its cost advantages, geographical benefits in China, and product differentiation in non-food phosphate solutions. The presentation includes non-GAAP financial measures, such as Adjusted EBITDA, to facilitate performance comparisons.